Elvia Cowan - Sep 5, 2023 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
SVP, Finance
Signature
Elvia Cowan, by /s/ Ron A. Metzger, Attorney-in-Fact
Stock symbol
PCVX
Transactions as of
Sep 5, 2023
Transactions value $
-$31,977
Form type
4
Date filed
9/6/2023, 05:34 PM
Previous filing
Mar 3, 2023
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Tax liability -$32K -627 -7.91% $51.00 7.3K Sep 5, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares surrendered to the Issuer to cover applicable tax withholding obligations realized upon the vesting of restricted stock units.
F2 Includes 678 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2023.